在台湾放射肿瘤学会理事陈裕仁医师的戮力协助下，双方签约仪式，由AME出版社汪道远社长及台湾放射肿瘤学会理事长，同时也是中国医药大学副校长的赵坤山教授代表出席，该签约仪式亦邀请到AME旗下TCR期刊主编Prof. Eric Y. Chuang出席，一同见证这一刻。这是AME进军台湾的第一场战役，可谓是AME获得国际组织认可的又一新里程碑，亦是台湾放射肿瘤学会为积极提高学术影响力而跨出的一大步。
图1. 左起马偕医院陈裕仁主任、中国医药大学赵坤山副校长（学会理事长）、AME汪道远社长、TCR主编Prof. Eric Y. Chuang
AME与台湾放射肿瘤学会的此次「联姻」，源自于TCR期刊主编Prof. Eric Y. Chuang的引荐。双方在年初会面时便已播下合作的种子，在短期间内形成共识，加速了这本期刊的诞生。因此，AME与台湾放射肿瘤学会于2017年中正式决定携手合作，由具有丰富出版专业医学期刊经验的AME出版社，为该学会注入新血，在双方合作下，互蒙其利，齐心将眼光及野心扩展至全球。我们期许这本期刊，对外，能够有效提高肿瘤和相关疾病之放射治疗及相关诊疗与学术研究水准；对内，可以藉由这个学术平台，增进交流切磋的机会，继而强化学会会员与国内外有关学术团体、学者之交流与合作力道。
AME Publishing Company （简称 AME，其代表 Academic Made Easy, Excellent and Enthusiastic；中文翻译为：欲穷千里目，快乐搞学术；www.amegroups.com），创立于 2009 年 7 月，是一个极其年轻的新创公司。AME以「科学研究（Research）」为主线，其核心价值观第一条是：Patients Come First！AME 专注于国际医学类期刊和书籍的出版和医疗科研资讯成果的推广，经过八年的积累，目前出版了40馀本涵盖肿瘤、心血管、胸部疾病、泌尿外科等不同领域的学术期刊（3本SCI收录，18本PubMed收录），40馀本医学图书，主办100多场线下学术会议。
台湾放射肿瘤学会已创立二十馀年，为该领域首屈一指的学术单位，举凡相关领域医师，大多已加入该单位，并具有学会员之资格。台湾放射肿瘤学会每年举办相关科技之学术演讲及讨论会，并发表有关放射肿瘤学与相关科技之学术论文及出版有关刊物。在遇见AME之前，已创办有「放射治疗与肿瘤学」(THERAPEUTIC RADIOLOGY AND ONCOLOGY)杂志，接受放射肿瘤学、放射生物学、保健物理学、放射物理学及其他相关肿瘤学等方面的中英文稿件。
The Collaboration between AME Publishing Company and Taiwan Society for Therapeutic Radiology and Oncology (TASTRO)
‘AME Publishing Company’ (AME) and ‘Taiwan Society for Therapeutic Radiology and Oncology’ (TASTRO) officially signed a contract on July 18th, 2017, laying down their cooperation in co-publishing a journal in the near future.
With the help of Prof. Yu-Jen Chen, the Director of TASTRO, the contract was signed by Mr. Stephen D. Wang, Founder and Chief Executive Officer of AME and Dr. Kun-Shan Zhao, the President of TASTRO and Vice President of China Medical University. Prof. Eric Y. Chuang, the Chief Editor of Translational Cancer Research (TCR), was also invited to witness this historical moment. This is the first time AME Publishing Company has burst into Taiwan’s market, and it is also a milestone for AME to be recognized by more international institutions. Signing this contract also allows TASTRO to increase its academic impact.
The collaboration is a result of the recommendation from Prof. Eric Y. Chuang. As a matter of fact, the seed of cooperation between the two parties were sowed at the beginning of the year. Reaching a consensus in a short period of time, it is expected that the journal will be published in the foreseeable future. AME Publishing Company, with considerable experience in publishing medical journals, will help bring vigor into Taiwan Society for Therapeutic Radiology and Oncology. Through the collaboration, both parties wish to mutually benefit each other and expand their influence to the globe. Not only do we hope this journal can enhance the academic level of Therapeutic Radiology and Oncology, but also foster communications among academic groups and scholars locally and internationally.
Introduction of AME Publishing Company
AME Publishing Company was established in July, 2009. (AME stands for Academic Made Easy, Excellent and Enthusiastic; the Chinese translation is 欲穷千里目，快乐搞学术; URL: www.amegroups.com) It is a start-up company aiming at scientific research with its primary core value ‘patients come first!’ Over the years, AME has published more than 40 medical journals, including the Journal of Thoracic Disease (JTD), Translational Cancer Research (TCR) and Hepatobiliary Surgery and Nutrition (HBSN), et al. So far, three AME journals have been indexed in SCI, and eighteen of them have been included in PubMed. AME has also hosted over 100 academic meetings in various forms.
Introduction of Taiwan Society for Therapeutic Radiology and Oncology
Taiwan Society for Therapeutic Radiology and Oncology was established over 2 decades ago. As the top institution in its profession, TASTRO has recruited numerous doctors studying Therapeutic Radiology and Oncology. Every year, it holds academic talks and seminars, and publishes academic papers and publications about Therapeutic Radiology and Oncology. Prior to cooperating with AME Publishing Company, TASTRO has already published the THERAPEUTIC RADIOLOGY AND ONCOLOGY, which accepts both Chinese and English manuscripts in the fields of Radiation Oncology, Radiation Biology, Health Physics, Radiation Physics and other Oncology-related disciplines.